Global Bionic Bone Market Research Report 2024

Publication ID:

PB508240772

Publication Date:

August 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Bionic bone can "develop" in the living body, and can also allow autologous cells to grow in the artificial bone. Eventually, the artificial bone and natural bone will grow together well and integrate into the animal's internal environment.
The global Bionic Bone market was valued at US$ 1654 million in 2023 and is anticipated to reach US$ 2555 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
The global medical device market is estimated to be US$603.3 billion in 2023, with a compound annual growth rate of 5% expected in the next six years. Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due to the increasing demand for healthcare from an aging population, the rising prevalence of chronic and infectious diseases, and the expansion of emerging markets. The medical device market plays an important role in the healthcare spending industry. The medical device market is driven by a variety of factors, including increasing global demand for advanced medical services, advancements in medical technology, growing geriatric population, increasing medical expenditures, and increasing awareness of early stage disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Bionic Bone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bionic Bone.
Report Scope
The Bionic Bone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bionic Bone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bionic Bone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NovaBone Products, LLC
Olympus Terumo Biomaterials Corp.
Bioscience
Wright
Johnson & Johnson
Allgens
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Chengdu Guona Technology Co., Ltd.
Shanghai Bio-lu Biomaterials Co., Ltd.
China-TianJin Sannie Bioengineering Technology Co., Ltd.
Yenssen Biotech
Segment by Type
Joints Type
Spinal Type
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bionic Bone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bionic Bone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Bionic Bone Market Overview
1.1 Product Overview and Scope of Bionic Bone
1.2 Bionic Bone Segment by Type
1.2.1 Global Bionic Bone Market Value Comparison by Type (2024-2030)
1.2.2 Joints Type
1.2.3 Spinal Type
1.2.4 Others
1.3 Bionic Bone Segment by Application
1.3.1 Global Bionic Bone Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Bionic Bone Market Size Estimates and Forecasts
1.4.1 Global Bionic Bone Revenue 2019-2030
1.4.2 Global Bionic Bone Sales 2019-2030
1.4.3 Global Bionic Bone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bionic Bone Market Competition by Manufacturers
2.1 Global Bionic Bone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bionic Bone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bionic Bone Average Price by Manufacturers (2019-2024)
2.4 Global Bionic Bone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bionic Bone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bionic Bone, Product Type & Application
2.7 Bionic Bone Market Competitive Situation and Trends
2.7.1 Bionic Bone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bionic Bone Players Market Share by Revenue
2.7.3 Global Bionic Bone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bionic Bone Retrospective Market Scenario by Region
3.1 Global Bionic Bone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bionic Bone Global Bionic Bone Sales by Region: 2019-2030
3.2.1 Global Bionic Bone Sales by Region: 2019-2024
3.2.2 Global Bionic Bone Sales by Region: 2025-2030
3.3 Global Bionic Bone Global Bionic Bone Revenue by Region: 2019-2030
3.3.1 Global Bionic Bone Revenue by Region: 2019-2024
3.3.2 Global Bionic Bone Revenue by Region: 2025-2030
3.4 North America Bionic Bone Market Facts & Figures by Country
3.4.1 North America Bionic Bone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bionic Bone Sales by Country (2019-2030)
3.4.3 North America Bionic Bone Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bionic Bone Market Facts & Figures by Country
3.5.1 Europe Bionic Bone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bionic Bone Sales by Country (2019-2030)
3.5.3 Europe Bionic Bone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bionic Bone Market Facts & Figures by Country
3.6.1 Asia Pacific Bionic Bone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bionic Bone Sales by Country (2019-2030)
3.6.3 Asia Pacific Bionic Bone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bionic Bone Market Facts & Figures by Country
3.7.1 Latin America Bionic Bone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bionic Bone Sales by Country (2019-2030)
3.7.3 Latin America Bionic Bone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bionic Bone Market Facts & Figures by Country
3.8.1 Middle East and Africa Bionic Bone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bionic Bone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bionic Bone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bionic Bone Sales by Type (2019-2030)
4.1.1 Global Bionic Bone Sales by Type (2019-2024)
4.1.2 Global Bionic Bone Sales by Type (2025-2030)
4.1.3 Global Bionic Bone Sales Market Share by Type (2019-2030)
4.2 Global Bionic Bone Revenue by Type (2019-2030)
4.2.1 Global Bionic Bone Revenue by Type (2019-2024)
4.2.2 Global Bionic Bone Revenue by Type (2025-2030)
4.2.3 Global Bionic Bone Revenue Market Share by Type (2019-2030)
4.3 Global Bionic Bone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bionic Bone Sales by Application (2019-2030)
5.1.1 Global Bionic Bone Sales by Application (2019-2024)
5.1.2 Global Bionic Bone Sales by Application (2025-2030)
5.1.3 Global Bionic Bone Sales Market Share by Application (2019-2030)
5.2 Global Bionic Bone Revenue by Application (2019-2030)
5.2.1 Global Bionic Bone Revenue by Application (2019-2024)
5.2.2 Global Bionic Bone Revenue by Application (2025-2030)
5.2.3 Global Bionic Bone Revenue Market Share by Application (2019-2030)
5.3 Global Bionic Bone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 NovaBone Products, LLC
6.1.1 NovaBone Products, LLC Corporation Information
6.1.2 NovaBone Products, LLC Description and Business Overview
6.1.3 NovaBone Products, LLC Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 NovaBone Products, LLC Bionic Bone Product Portfolio
6.1.5 NovaBone Products, LLC Recent Developments/Updates
6.2 Olympus Terumo Biomaterials Corp.
6.2.1 Olympus Terumo Biomaterials Corp. Corporation Information
6.2.2 Olympus Terumo Biomaterials Corp. Description and Business Overview
6.2.3 Olympus Terumo Biomaterials Corp. Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Olympus Terumo Biomaterials Corp. Bionic Bone Product Portfolio
6.2.5 Olympus Terumo Biomaterials Corp. Recent Developments/Updates
6.3 Bioscience
6.3.1 Bioscience Corporation Information
6.3.2 Bioscience Description and Business Overview
6.3.3 Bioscience Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bioscience Bionic Bone Product Portfolio
6.3.5 Bioscience Recent Developments/Updates
6.4 Wright
6.4.1 Wright Corporation Information
6.4.2 Wright Description and Business Overview
6.4.3 Wright Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wright Bionic Bone Product Portfolio
6.4.5 Wright Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Bionic Bone Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Allgens
6.6.1 Allgens Corporation Information
6.6.2 Allgens Description and Business Overview
6.6.3 Allgens Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Allgens Bionic Bone Product Portfolio
6.6.5 Allgens Recent Developments/Updates
6.7 Hangzhou Jiuyuan Gene Engineering Co., Ltd.
6.6.1 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Corporation Information
6.6.2 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Description and Business Overview
6.6.3 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Bionic Bone Product Portfolio
6.7.5 Hangzhou Jiuyuan Gene Engineering Co., Ltd. Recent Developments/Updates
6.8 Chengdu Guona Technology Co., Ltd.
6.8.1 Chengdu Guona Technology Co., Ltd. Corporation Information
6.8.2 Chengdu Guona Technology Co., Ltd. Description and Business Overview
6.8.3 Chengdu Guona Technology Co., Ltd. Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chengdu Guona Technology Co., Ltd. Bionic Bone Product Portfolio
6.8.5 Chengdu Guona Technology Co., Ltd. Recent Developments/Updates
6.9 Shanghai Bio-lu Biomaterials Co., Ltd.
6.9.1 Shanghai Bio-lu Biomaterials Co., Ltd. Corporation Information
6.9.2 Shanghai Bio-lu Biomaterials Co., Ltd. Description and Business Overview
6.9.3 Shanghai Bio-lu Biomaterials Co., Ltd. Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai Bio-lu Biomaterials Co., Ltd. Bionic Bone Product Portfolio
6.9.5 Shanghai Bio-lu Biomaterials Co., Ltd. Recent Developments/Updates
6.10 China-TianJin Sannie Bioengineering Technology Co., Ltd.
6.10.1 China-TianJin Sannie Bioengineering Technology Co., Ltd. Corporation Information
6.10.2 China-TianJin Sannie Bioengineering Technology Co., Ltd. Description and Business Overview
6.10.3 China-TianJin Sannie Bioengineering Technology Co., Ltd. Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 China-TianJin Sannie Bioengineering Technology Co., Ltd. Bionic Bone Product Portfolio
6.10.5 China-TianJin Sannie Bioengineering Technology Co., Ltd. Recent Developments/Updates
6.11 Yenssen Biotech
6.11.1 Yenssen Biotech Corporation Information
6.11.2 Yenssen Biotech Bionic Bone Description and Business Overview
6.11.3 Yenssen Biotech Bionic Bone Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yenssen Biotech Bionic Bone Product Portfolio
6.11.5 Yenssen Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bionic Bone Industry Chain Analysis
7.2 Bionic Bone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bionic Bone Production Mode & Process
7.4 Bionic Bone Sales and Marketing
7.4.1 Bionic Bone Sales Channels
7.4.2 Bionic Bone Distributors
7.5 Bionic Bone Customers
8 Bionic Bone Market Dynamics
8.1 Bionic Bone Industry Trends
8.2 Bionic Bone Market Drivers
8.3 Bionic Bone Market Challenges
8.4 Bionic Bone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

NovaBone Products, LLC
Olympus Terumo Biomaterials Corp.
Bioscience
Wright
Johnson & Johnson
Allgens
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Chengdu Guona Technology Co., Ltd.
Shanghai Bio-lu Biomaterials Co., Ltd.
China-TianJin Sannie Bioengineering Technology Co., Ltd.
Yenssen Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂